Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sei Yonezawa

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Advanced Drug Delivery Reviews|August 10, 2020
Recent advances in siRNA delivery mediated by lipid-based nanoparticlesSei Yonezawa, Hiroyuki Koide, Tomohiro Asai
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor modelSei Yonezawa, Tomohiro Asai, Naoto Oku
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
siRNA Vehicles for High Endosomal EscapabilityHiroyuki Koide, Sei Yonezawa, Tomohiro Asai
Biochemical and Biophysical Research Communications|May 14, 2023
Improvement of LXR-mediated lipid metabolism in nephrotic model kidney accompanied by suppression of inflammation and fibrosisSei Yonezawa, Yasushi Kawasaki, Yasuhiro Natori, et al.
Biochemical and Biophysical Research Communications|November 26, 2018
Each liver X receptor (LXR) type has a different purpose in different situationsSei Yonezawa, Mizuho Abe, Yasushi Kawasaki, et al.
Cancer|April 4, 2003
Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizerYoshito Takeuchi, Kohta Kurohane, Kanae Ichikawa, et al.
Biological & Pharmaceutical Bulletin|June 10, 2004
Suppressed permeation of linoleic acid in a liposomal formulation through reconstructed skin tissueYasutami Shigeta, Hiromichi Imanaka, Sei Yonezawa, et al.
Cancer Letters|March 24, 2004
Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growthKanae Ichikawa, Yoshito Takeuchi, Sei Yonezawa, et al.
Biological & Pharmaceutical Bulletin|March 25, 2025
Process Optimization of Charge-Reversible Lipid Nanoparticles for Cytosolic Protein Delivery Using the Design-of-Experiment ApproachDai Oyama, Masako Okada, Furan Song, et al.
ACS Omega|January 15, 2024
Engineering Temperature-Responsive Polymer Nanoparticles that Load and Release Paclitaxel, a Low-Molecular-Weight Anticancer DrugHiroyuki Koide, Kazuma Yamaguchi, Keijiro Sato, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Advanced Drug Delivery Reviews|August 10, 2020
Recent advances in siRNA delivery mediated by lipid-based nanoparticlesSei Yonezawa, Hiroyuki Koide, Tomohiro Asai
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor modelSei Yonezawa, Tomohiro Asai, Naoto Oku
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
siRNA Vehicles for High Endosomal EscapabilityHiroyuki Koide, Sei Yonezawa, Tomohiro Asai
Biochemical and Biophysical Research Communications|May 14, 2023
Improvement of LXR-mediated lipid metabolism in nephrotic model kidney accompanied by suppression of inflammation and fibrosisSei Yonezawa, Yasushi Kawasaki, Yasuhiro Natori, et al.
Biochemical and Biophysical Research Communications|November 26, 2018
Each liver X receptor (LXR) type has a different purpose in different situationsSei Yonezawa, Mizuho Abe, Yasushi Kawasaki, et al.
Cancer|April 4, 2003
Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizerYoshito Takeuchi, Kohta Kurohane, Kanae Ichikawa, et al.
Biological & Pharmaceutical Bulletin|June 10, 2004
Suppressed permeation of linoleic acid in a liposomal formulation through reconstructed skin tissueYasutami Shigeta, Hiromichi Imanaka, Sei Yonezawa, et al.
Cancer Letters|March 24, 2004
Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growthKanae Ichikawa, Yoshito Takeuchi, Sei Yonezawa, et al.
Biological & Pharmaceutical Bulletin|March 25, 2025
Process Optimization of Charge-Reversible Lipid Nanoparticles for Cytosolic Protein Delivery Using the Design-of-Experiment ApproachDai Oyama, Masako Okada, Furan Song, et al.
ACS Omega|January 15, 2024
Engineering Temperature-Responsive Polymer Nanoparticles that Load and Release Paclitaxel, a Low-Molecular-Weight Anticancer DrugHiroyuki Koide, Kazuma Yamaguchi, Keijiro Sato, et al.
Pageof 4